Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
US Department of Justice
Farmers Insurance
Healthtrust
Boehringer Ingelheim
Covington
Argus Health
Mallinckrodt

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEPODUR

« Back to Dashboard

Clinical Trials for Depodur

Trial ID Title Status Sponsor Phase Summary
NCT00335517 Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients Completed EKR Therapeutics, Inc N/A The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.
NCT00335517 Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients Completed University of Rochester N/A The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.
NCT00456638 Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG) Withdrawn Drexel University College of Medicine N/A The purpose of this study is to determine whether epidural Depodur alleviates the pain of OP-CABG surgery. This includes pain associated with sternotomy, retraction, dissection and other tissue insults, as well as the induced inflammatory system and effects from prolonged ventilation in the ICU setting.
NCT00708318 Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects Completed YM BioSciences Phase 1 This was a pilot, phase I, two-period, fasting, bioavailability, safety,and pharmacokinetic study evaluating single dose of i.v. fentanyl (200 µg) and single doses of 2 mL or 3 mL inhaled AeroLEF (500 µg/mL) delivered by nebulization with the AeroEclipse BAN device administered in normal healthy non-smoking subjects.
NCT00728832 A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery Completed Pacira Pharmaceuticals, Inc Phase 1 The primary purpose of this study is to evaluate the effects of lidocaine/epinephrine test dose administration on the PK profile of a single epidural dose of DepoDur (extended-release epidural morphine) in patients undergoing major upper abdominal surgery. A secondary objective was to evaluate the safety and efficacy profile.
NCT00728832 A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery Completed EKR Therapeutics, Inc Phase 1 The primary purpose of this study is to evaluate the effects of lidocaine/epinephrine test dose administration on the PK profile of a single epidural dose of DepoDur (extended-release epidural morphine) in patients undergoing major upper abdominal surgery. A secondary objective was to evaluate the safety and efficacy profile.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Depodur

Condition Name

Condition Name for Depodur
Intervention Trials
Hip Arthroplasty 1
Spastic Cerebral Palsy 1
Healthy 1
Postoperative Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Depodur
Intervention Trials
Pain, Postoperative 2
Muscle Spasticity 1
Cerebral Palsy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Depodur

Trials by Country

Trials by Country for Depodur
Location Trials
United States 7
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Depodur
Location Trials
New York 2
Missouri 1
North Carolina 1
Kentucky 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Depodur

Clinical Trial Phase

Clinical Trial Phase for Depodur
Clinical Trial Phase Trials
Phase 4 2
Phase 1 2
N/A 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Depodur
Clinical Trial Phase Trials
Completed 5
Unknown status 3
Withdrawn 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Depodur

Sponsor Name

Sponsor Name for Depodur
Sponsor Trials
EKR Therapeutics, Inc 4
Washington University School of Medicine 1
Drexel University College of Medicine 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Depodur
Sponsor Trials
Other 8
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKesson
US Army
Federal Trade Commission
Cerilliant
Deloitte
Baxter
Fuji
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.